- Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol. Van de Werf, F., Vanhaecke, J., Jang, I.K., Flameng, W., Collen, D., De Geest, H. Circulation (1987)